A detailed history of Pnc Financial Services Group, Inc. transactions in Anixa Biosciences Inc stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 3,039 shares of ANIX stock, worth $7,840. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,039
Previous 3,039 -0.0%
Holding current value
$7,840
Previous $6,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$2.21 - $3.35 $442 - $670
-200 Reduced 6.17%
3,039 $6,000
Q1 2024

May 10, 2024

BUY
$3.08 - $5.02 $616 - $1,003
200 Added 6.58%
3,239 $10,000
Q3 2023

Nov 13, 2023

BUY
$2.97 - $3.87 $9,025 - $11,760
3,039 New
3,039 $9,000
Q2 2019

Aug 09, 2019

SELL
$3.47 - $4.75 $1,422 - $1,947
-410 Closed
0 $0
Q4 2018

Feb 08, 2019

BUY
$3.37 - $6.59 $1,381 - $2,701
410 New
410 $1,000

Others Institutions Holding ANIX

About Anixa Biosciences Inc


  • Ticker ANIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,661,700
  • Market Cap $79.1M
  • Description
  • Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...
More about ANIX
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.